Listed by the USPTO as ZHANG, KAIJIANG
Tech Center 1600 • Art Units: 1612 1639 1644 1675 1682 1684
This examiner grants 77% of resolved cases
ZHANG, KAIJIANG has resolved 706 cases in Tech Center 1600 and Art Unit 1612. The allowance rate is 77.2%, and the interview lift is 34.3%. The median time to allowance is 992 days. The substantial record combines a high allowance rate with a meaningful interview association, supporting a prosecution approach that integrates direct discussion with technically focused amendments.
The company portfolio includes Fred Hutchinson Cancer Research Center, 10x Genomics Inc., and Grail LLC. The leading firms are BROWN RUDNICK LLP, CHOATE, HALL & STEWART LLP, and Clark+Elbing LLP. These names reflect relevant biotechnology applicants and counsel whose filings may offer useful precedents for work in the art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18323091 | METHODS FOR PRINTING CELLS AND GENERATING ARRAYS OF BARCODED CELLS | Non-Final OA | 10x Genomics, Inc. |
| 17820560 | METHODS FOR PROCESSING NUCLEIC ACID MOLECULES | Final Rejection | 10x Genomics, Inc. |
| 18187449 | METHODS AND COMPOSITIONS FOR QUANTITATION OF PROTEINS AND RNA | Non-Final OA | Becton, Dickinson and Company |
| 17963119 | MULTI-SEQUENCE CAPTURE SYSTEM | Non-Final OA | University of Utah Research Foundation |
| 17856923 | CHEMICAL METHODS FOR PRODUCING TAGGED NUCLEOTIDES | Non-Final OA | ROCHE SEQUENCING SOLUTIONS, INC. |
| 17924425 | POLYNUCLEOTIDE ARRAYS | Final Rejection | Oxford University Innovation Limited |
| 17978130 | SEQUENCING KITS | Non-Final OA | ILLUMINA, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy77.2% of resolved applications examined by Kaijiang Zhang were allowed (706 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +34.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kaijiang Zhang took 992 days on average from filing to allowance.
Kaijiang Zhang examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
